December 27, 2007 - After a longer-than-expected maintenance shutdown, production of radioisotopes for molecular imaging ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
December 26, 2007 - The loss of more than 50 percent of the North American Mo-99 supply is now having an impact on the ...
December 17, 2007 - Bristol-Myers Squibb Co. said Monday it has signed an agreement to sell its medical imaging unit to ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
December 13, 2007 – A Canadian nuclear reactor that makes and distributes globally more than two-thirds of the world’s ...
December 5, 2007 - Bristol-Myers Squibb will divest its medical imaging division as part of an initiative to maximize ...
December 1, 2007 – Bayer Healthcare Pharmaceuticals previewed at RSNA 2007 VistaTrak, a password protected contrast ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
Bayer Healthcare Pharmaceuticals responded to concerns by the Joint Commission on Accreditation of Healthcare ...
November 21, 2007 - Bayer HealthCare Pharmaceuticals Inc. has signed a three-year contract by MedAssets Supply Chain ...
November 19, 2007 – Covidien Imaging Solutions, a subsidiary of Covidien Ltd., signed a multi-year deal to supply X-ray ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
November 9, 2007 - Bayer HealthCare Pharmaceuticals announced that the company has been awarded a three-year contract ...
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
October 30, 2007 - Bracco Diagnostics, the subsidiary of contrast media developer Bracco Imaging, will acquire E-Z-EM at ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
October 24, 2007 — Study results presented this week at the Transcatheter Cardiovascular Therapeutic (TCT) annual ...
E-Z-EM’s IRiS 2.0, the latest version of its Injector Reporting information System (IRiS) software package, helps turn E ...
This convenient, point-of-care (POC), handheld device analyzes a finger prick sample of blood for creatinine levels—an ...
Guerbet’s X-ray contrast agent, Oxilan (ioxilan), is a nonionic low-viscous and low-osmolar monomer. Significant ...
EmpowerCTA injector offers both E-Z-EM’s patented extravasation detection accessory (EDA) and a saline chase. Modular CT ...
The MEDRAD Stellant CT Injection System provides saline flush capabilities and protocol options. The DualFlow upgrade ...
GE Healthcare’s’ VISIPAQUE has an osmolality equal to that of blood, and is also the only contrast medium formulated ...
October 11, 2007 — NewSouth Innovations Pty Ltd, the technology transfer arm of University of New South Wales (UNSW) ...